Alnylam Pharmaceuticals
ALNY
#696
Rank
โ‚น3.479 T
Marketcap
โ‚น26,063
Share price
1.13%
Change (1 day)
-7.24%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company